![]() |
市場調查報告書
醫藥品連續生產的全球市場:各產品、用途、終端用戶的市場機會與產業預測(2019年∼2026年)Pharmaceutical Continuous Manufacturing Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026 |
||||||
出版商 | Allied Market Research | 商品編碼 | 923971 | ||||
出版日期 | 內容資訊 | 英文 245 Pages 商品交期: 2-3個工作天內 |
|||||
價格 |
|
醫藥品連續生產的全球市場:各產品、用途、終端用戶的市場機會與產業預測(2019年∼2026年) Pharmaceutical Continuous Manufacturing Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026 | ||
出版日期: 2019年12月31日 | 內容資訊: 英文 245 Pages |
|
全球醫藥品連續生產市場,2018年價值3億9,300萬美元,預計從2019年到2026年以10.2%的年複合成長率發展,到2026年成長到8億5,500萬美元。從傳統的醫藥品生產流程轉移到醫藥品連續生產,連續生產系統的技術進步,發展中國家的連續生產系統的認識度提高,生產量的變動縮小,產量比率的改善,運用成本的降低等要素,預計促進這個市場成長。
本報告提供全球醫藥品連續生產市場調查,市場概要,各產品、用途、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。
The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.
Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.
The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.
Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.
Moreover, the CM process is more time-efficient, reduces energy needs, helps to increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.
The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of four major regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
By Product
By Region
Table 01. Global Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026 ($Million)
Table 02. Integrated Continuous Systems Market, By Region, 2018-2026 ($Million)
Table 03. Semi-Continuous Systems Market, By Region, 2018-2026 ($Million)
Table 04. Others Market, By Region, 2018-2026 ($Million)
Table 05. Global Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026 ($Million)
Table 06. Final Drug Product Manufacturing Market, By Region, 2018-2026 ($Million)
Table 07. Api Manufacturing Market, By Region, 2018-2026 ($Million)
Table 08. Global Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026 ($Million)
Table 09. Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Region, 2018-2026 ($Million)
Table 10. Pharmaceutical Continuous Manufacturing For Contract Manufacturing Organizations, By Region, 2018-2026 ($Million)
Table 11. Pharmaceutical Continuous Manufacturing For Others, By Region, 2018-2026 ($Million)
Table 12. Pharmaceutical Continuous Manufacturing Market Revenue, By Region, 2018-2026 ($Million)
Table 13. North America Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)
Table 14. U.S. Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 15. U.S. Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 16. U.S. Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 17. Canada Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 18. Canada Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 19. Canada Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 20. Mexico Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 21. Mexico Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 22. Mexico Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 23. North America Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 24. North America Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 25. North America Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 26. Europe Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)
Table 27. Germany Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 28. Germany Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 29. Germany Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 30. France Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 31. France Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 32. France Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 33. Uk Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 34. Uk Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 35. Uk Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 36. Italy Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 37. Italy Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 38. Italy Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 39. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 40. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 41. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 42. Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 43. Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 44. Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 45. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)
Table 46. Japan Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 47. Japan Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 48. Japan Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 49. China Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 50. China Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 51. China Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 52. India Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 53. India Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 54. India Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 55. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 56. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 57. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 58. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 59. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 60. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 61. Lamea Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)
Table 62. Brazil Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 63. Brazil Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 64. Brazil Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 65. South Africa Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 66. South Africa Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 67. South Africa Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 68. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 69. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 70. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 71. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 72. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 73. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 74. Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026
Table 75. Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026
Table 76. Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026
Table 77. Coperion: Company Snapshot
Table 78. Coperion: Business Segment
Table 79. Gea Group: Company Snapshot
Table 80. Gea Group: Operating Segments
Table 81. Gea Group: Product Portfolio
Table 82. Lodige: Company Snapshot
Table 83. Lodige: Operating Segments
Table 84. Lodige: Product Portfolio
Table 85. Glatt: Company Snapshot
Table 86. Glatt: Operating Segments
Table 87. Glatt: Product Portfolio
Table 88. Hosokawa: Company Snapshot
Table 89. Hosokawa: Product Portfolio
Table 90. Korsch: Company Snapshot
Table 91. Korsch: Operating Segments
Table 92. Korsch: Product Portfolio
Table 93. L.B. Bohle: Company Snapshot
Table 94. L.B. Bohle: Operating Segments
Table 95. Munson: Company Snapshot
Table 96. L.B. Bohle: Operating Product Segments
Table 97. Munson: Product Portfolio
Table 98. Bosch Group: Company Snapshot
Table 99. Bosch Group: Operating Segments
Table 100. Bosch Group: Product Portfolio
Table 101. Thermo Fisher Scientific: Company Snapshot
Table 102. Thermo Fisher Scientific: Operating Segments
Table 103. Thermo Fisher Scientific: Product Portfolio
Figure 01. Global Pharmaceutical Continuous Manufacturing Market Segmentation
Figure 02. Top Investment Pockets, 2018
Figure 03. Market Player Positioning, 2018
Figure 04. Impact Analysis
Figure 05. Comparative Analysis of Integrated Continuous Systems Market, By Country, 2018 & 2026 ($Million)
Figure 06. Comparative Analysis of Semi-Continuous Systems Market, By Country, 2018 & 2026 ($Million)
Figure 07. Comparative Analysis of Control & Software Market, By Country, 2018 & 2026 ($Million)
Figure 08. Comparative Analysis of Final Drug Product Manufacturing Market, By Country, 2018 & 2026 ($Million)
Figure 09. Comparative Analysis of Api Manufacturing Market, By Country, 2018 & 2026 ($Million)
Figure 10. Comparative Analysis of Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Country, 2018 & 2026 ($Million)
Figure 11. Comparative Analysis Pharmaceutical Continuous Manufacturing Market For Contract Manufacturing Organizations, By Country, 2018 & 2026 (%)
Figure 12. Comparative Analysis of Pharmaceutical Continuous Manufacturing Market For Others, By Country, 2018 & 2026 (%)
Figure 13. Net Sales, 2016-2018 ($Million)
Figure 14. Gea Group: Net Sales By Segment, 2018 (%)
Figure 15. Gea Group: Net Sales By Region, 2018 (%)
Figure 16. Net Sales, 2016-2018 ($Million)
Figure 17. Hosokawa: Net Sales By Segment, 2018 (%)
Figure 18. Hosokawa: Net Sales By Geography, 2018 (%)
Figure 19. Net Sales, 2016-2018 ($Million)
Figure 20. Bosch Group: Net Sales By Segment, 2018 (%)
Figure 21. Bosch Group: Net Sales By Revenue, 2018 (%)
Figure 22. Thermo Fisher Scientific: Revenue, 2016-2018 ($Million)
Figure 23. Thermo Fisher Scientific: Revenue Share, By Segment, 2018 (%)
Figure 24. Thermo Fisher Scientific: Revenue Share, By Region, 2018 (%)